Biomechanical study on aortic-mitral coupling in transcatheter aortic valve replacement
经导管主动脉瓣置换术中主动脉-二尖瓣耦合的生物力学研究
基本信息
- 批准号:9274379
- 负责人:
- 金额:$ 23.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-06-01 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAlternative TherapiesAortic Valve StenosisBiomechanicsCardiacCharacteristicsClinicalClinical ResearchComputer SimulationComputing MethodologiesCoupledCouplingDataData SetDevelopmentDevicesEchocardiographyEngineeringEtiologyGenerationsGeometryGoalsHospitalsImageIncidenceInterventionInvestigationLeftLeft ventricular structureMagnetic Resonance ImagingMethodsMitral ValveMitral Valve InsufficiencyModelingOperative Surgical ProceduresPatient riskPatient-Focused OutcomesPatientsPhysiologicalPositioning AttributeProceduresProcessReportingResearchRetrospective StudiesSeveritiesShapesSideStentsSymptomsSystemTimeX-Ray Computed Tomographyaortic valveaortic valve replacementclinical decision-makingcohortcomputer frameworkhemodynamicshigh riskimplantationimprovedinnovationprospectivepublic health relevancerepairedsimulation
项目摘要
DESCRIPTION (provided by applicant): Significant mitral regurgitation (MR) is a common ailment among patients with severe aortic stenosis (AS), and the management of these patients is challenging because the aortic and mitral valves are interdependent. Transcatheter aortic valve replacement (TAVR) can significantly reduce AS symptoms in high-risk patients; however, this procedure displaces the aortic-mitral curtain delineating the two valves, and may consequently have unexpected and adverse effects on mitral valve function. Studies have shown that MR severity is improved in approximately 50% of patients following TAVR, but unchanged or even worsened in others. The objective of this study is to develop a coupled mitral-aortic-left ventricle (LV) computational modeling framework to investigate the biomechanics involved in TAVR in patients with concomitant MR, in order to improve our understanding of mitral-aortic coupling and predict the effects of TAVR on MR severity. To achieve this goal, mitral-aortic-LV coupling computational models will be developed to investigate pre-TAVR hemodynamics, and validated against clinical 3D echocardiogram (3DE) and Cardiac Magnectic Resonance (CMR) image data (Aim 1). The models will be used to simulate TAVR device deployment to investigate the impacts of TAVR on the mitral valve and MR severity, and validated against post-TAVR 3DE and CMR data (Aim 2). Through parametric study, the optimal TAVR device and deployment strategies to improve patient outcomes will be investigated through the validated computational methods of Aims 1 and 2 (Aim 3). The results from this study may provide scientific rationale to improve the current clinical decision-making process, including patient and TAVR device selection, TAVR device positioning and deployment strategy, and the selection of intervention methods for MR improvement.
描述(由申请人提供):显着二尖瓣反流(MR)是严重主动脉瓣狭窄(AS)患者的常见疾病,这些患者的治疗具有挑战性,因为主动脉瓣和二尖瓣是相互依赖的。经导管主动脉瓣置换术(TAVR)可显着减轻高危患者的AS症状;然而,该手术会移位界定两个瓣膜的主动脉-二尖瓣帘,因此可能对二尖瓣功能产生意想不到的不利影响。研究表明,TAVR 后大约 50% 的患者 MR 严重程度得到改善,但其他患者则没有变化甚至恶化。本研究的目的是开发一个二尖瓣-主动脉-左心室 (LV) 耦合计算模型框架,以研究合并 MR 患者的 TAVR 所涉及的生物力学,以提高我们对二尖瓣-主动脉耦合的理解并预测 TAVR 对 MR 严重程度的影响。为了实现这一目标,将开发二尖瓣-主动脉-左心室耦合计算模型来研究 TAVR 前的血流动力学,并根据临床 3D 超声心动图 (3DE) 和心脏磁共振 (CMR) 图像数据进行验证(目标 1)。这些模型将用于模拟 TAVR 设备部署,以研究 TAVR 对二尖瓣和 MR 严重程度的影响,并根据 TAVR 后 3DE 和 CMR 数据进行验证(目标 2)。通过参数研究,将通过目标 1 和 2(目标 3)的经过验证的计算方法来研究改善患者治疗效果的最佳 TAVR 设备和部署策略。本研究的结果可为改善当前的临床决策过程提供科学依据,包括患者和 TAVR 设备的选择、TAVR 设备的定位和部署策略以及改善 MR 的干预方法的选择。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Evaluation of transcatheter heart valve biomaterials: Computational modeling using bovine and porcine pericardium.
经导管心脏瓣膜生物材料的评估:使用牛和猪心包的计算模型。
- DOI:10.1016/j.jmbbm.2019.05.020
- 发表时间:2019
- 期刊:
- 影响因子:3.9
- 作者:Sulejmani,Fatiesa;Caballero,Andrés;Martin,Caitlin;Pham,Thuy;Sun,Wei
- 通讯作者:Sun,Wei
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Wei Sun其他文献
Wei Sun的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Wei Sun', 18)}}的其他基金
Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit
用于早期癌症评估的液体活检的竞争前合作:数据管理和协调单位
- 批准号:
10838127 - 财政年份:2023
- 资助金额:
$ 23.01万 - 项目类别:
Post-GWAS Functional Genomics Analysis to Define Pathogenic Mechanisms for Pulmonary Arterial Hypertension
GWAS 后功能基因组学分析确定肺动脉高压的致病机制
- 批准号:
10524975 - 财政年份:2022
- 资助金额:
$ 23.01万 - 项目类别:
Yersinia Outer-Membrane-Vesicle Vaccines Against Pneumonic Plague
鼠疫耶尔森氏菌外膜囊泡疫苗
- 批准号:
10673295 - 财政年份:2022
- 资助金额:
$ 23.01万 - 项目类别:
Yersinia Outer-Membrane-Vesicle Vaccines Against Pneumonic Plague
鼠疫耶尔森氏菌外膜囊泡疫苗
- 批准号:
10555332 - 财政年份:2022
- 资助金额:
$ 23.01万 - 项目类别:
Yersinia Outer-Membrane-Vesicle Vaccines Against Pneumonic Plague
鼠疫耶尔森氏菌外膜囊泡疫苗
- 批准号:
10441853 - 财政年份:2022
- 资助金额:
$ 23.01万 - 项目类别:
Post-GWAS Functional Genomics Analysis to Define Pathogenic Mechanisms for Pulmonary Arterial Hypertension
GWAS 后功能基因组学分析确定肺动脉高压的致病机制
- 批准号:
10697364 - 财政年份:2022
- 资助金额:
$ 23.01万 - 项目类别:
Statistical Methods for T Cell Receptor (TCR) Analysis
T 细胞受体 (TCR) 分析的统计方法
- 批准号:
10620574 - 财政年份:2022
- 资助金额:
$ 23.01万 - 项目类别:
Statistical Genetics and Genomics for Epidemiologic Research
流行病学研究的统计遗传学和基因组学
- 批准号:
10426287 - 财政年份:2018
- 资助金额:
$ 23.01万 - 项目类别:
A novel computing framework to automatically process cardiac valve image data and predict treatment outcomes
一种新颖的计算框架,可自动处理心脏瓣膜图像数据并预测治疗结果
- 批准号:
9973167 - 财政年份:2018
- 资助金额:
$ 23.01万 - 项目类别:
Yersinia pseudotuberculosis-based vaccines for plague and yersiniosis
基于假结核耶尔森氏菌的鼠疫和耶尔森氏菌疫苗
- 批准号:
9471106 - 财政年份:2016
- 资助金额:
$ 23.01万 - 项目类别:
相似海外基金
Development of education and dissemination methods for psychiatric nurses to introduce complementary and alternative therapies from the physical side
开发精神科护士的教育和传播方法,从身体方面引入补充和替代疗法
- 批准号:
26463484 - 财政年份:2014
- 资助金额:
$ 23.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Alternative therapies for antibiotic-resistant Helicobacter pylori infection
抗生素耐药性幽门螺杆菌感染的替代疗法
- 批准号:
23590890 - 财政年份:2011
- 资助金额:
$ 23.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Alternative Therapies for Benign Prostate Symptoms
良性前列腺症状的替代疗法
- 批准号:
8147503 - 财政年份:2010
- 资助金额:
$ 23.01万 - 项目类别:
Scientific evaluation of therapeutic effects and mechanism of alternative therapies using PET molecular imaging technique.
利用PET分子成像技术科学评估替代疗法的治疗效果和机制。
- 批准号:
21590754 - 财政年份:2009
- 资助金额:
$ 23.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Treating Burn injuries: First-aid and alternative therapies
治疗烧伤:急救和替代疗法
- 批准号:
nhmrc : 409902 - 财政年份:2006
- 资助金额:
$ 23.01万 - 项目类别:
NHMRC Postgraduate Scholarships
PREVENTING COGNITIVE DECLINE WITH ALTERNATIVE THERAPIES
通过替代疗法预防认知能力下降
- 批准号:
7206559 - 财政年份:2005
- 资助金额:
$ 23.01万 - 项目类别:
Alternative Therapies for Alcohol and Drug Abuse
酒精和药物滥用的替代疗法
- 批准号:
6861518 - 财政年份:2004
- 资助金额:
$ 23.01万 - 项目类别:
Alternative Therapies for Alcohol and Drug Abuse
酒精和药物滥用的替代疗法
- 批准号:
6952268 - 财政年份:2004
- 资助金额:
$ 23.01万 - 项目类别:
Alternative Therapies for Alcohol and Drug Abuse
酒精和药物滥用的替代疗法
- 批准号:
7115879 - 财政年份:2004
- 资助金额:
$ 23.01万 - 项目类别:
Alternative Therapies for Alcohol and Drug Abuse
酒精和药物滥用的替代疗法
- 批准号:
7237832 - 财政年份:2004
- 资助金额:
$ 23.01万 - 项目类别:














{{item.name}}会员




